commit f88b3292d8ba819acea6302994e6ae8afeba7558
Author: lashawndebeuze <lashawn.debeuzeville@topcompanygroup.com>
Date:   Fri Apr 3 06:57:18 2026 +0800

    Add Testosterone deficiency in the male

diff --git a/Testosterone-deficiency-in-the-male.md b/Testosterone-deficiency-in-the-male.md
new file mode 100644
index 0000000..69a41a2
--- /dev/null
+++ b/Testosterone-deficiency-in-the-male.md
@@ -0,0 +1,8 @@
+<br>
+<br>A study found non-depressed men older than 60 years to have a mean 5% decrease in a geriatric depression scale when administered testosterone. Two additional studies from the same group in non-depressed men with CHF did not show an effect of testosterone on the Beck Depression Inventory (BDI),20, 27 although the earlier of these studies concluded otherwise based on a finding that was not statistically significant. One of these studies could not be evaluated because only a composite score for mood and sexual function was reported. For example, men abusing anabolic steroids have been described as having "Roid Rage." We did not evaluate steroid abuse studies, but we reviewed studies on [buy testosterone online](https://lookingforjob.co/profile/jamesgaines200) preparations and their association with anger, aggression, and other mood alterations. Some studies of mood and behavior were designed to evaluate the potential adverse effects of anabolic steroid abuse.
+Unfavorable changes were reported in 2 studies 5, 25 and included increases in total cholesterol, LDL cholesterol, and triglycerides and decreases in HDL cholesterol in men evaluated as hypogonadal prior to androgen therapy. Favorable effects in 11 studies included 5–11% decreases in total cholesterol concentration and variable and inconsistent decreases in triglycerides and low-density lipoprotein (LDL) cholesterol. Serum or plasma concentrations of cholesterol fractions, triglycerides, and lipoproteins have been used as surrogate endpoints for cardiovascular risk, although they should not be mistaken for markers of cardiovascular adverse events. The improvements in exercise function appeared attributable to the response of men with baseline plasma [buy testosterone gel](http://159.75.27.114:3000/shaunakiley839) concentration 23 Another study showed no effect of IM testosterone enanthate on ejection fraction, although there was an improvement in a Doppler-based myocardial performance index. Intramuscular (IM) [buy testosterone online no prescription](http://82.156.98.34:3000/lateshasteffen) treatment for 12 weeks improved exercise capacity and reduced heart failure symptom scores without identifiable effects on left ventricular size or ejection fraction (EF). There was a decreased incidence of silent MI with testosterone treatment in 1 study. The remaining eight studies evaluated treatments of 2 to 24 weeks in duration.1, 3, 10, 11, 13–17 The 3 studies that looked at time to ST-segment depression found a benefit of testosterone supplementation.1, 14, 16|Acute illnesses should be considered when measuring testosterone levels, the presence of which can affect the accuracy of the test and lead to artificially decreased testosterone measurements. To ensure accuracy and precision, it is necessary to obtain at least two serum total testosterone measurements in an early morning fashion to diagnose patients with low testosterone. One strategy is to further evaluate patients using adjunctive tests, which might strengthen an argument for a short-term trial of testosterone therapy. Establishing total testosterone thresholds for a diagnosis of [buy testosterone enanthate online](http://39.100.117.84:3000/dedrajohnstone) deficiency is challenging considering the heterogeneity that exists in the testosterone deficiency literature. However, as the testosterone literature uses absolute values to define low [buy testosterone injections](http://124.236.46.74:9103/denishasweat9), the absolute value is ultimately the most important factor to determine whether patients may expect to achieve benefits with testosterone therapy. Evidence strength refers to the body of evidence available for a particular question and includes not only individual study quality but consideration of study design, consistency of findings across studies, adequacy of sample sizes, and generalizability of samples, settings, and treatments for the purposes of the guideline.|But you should address symptoms that interfere with your quality of life. Low testosterone may lead to weak bones (osteoporosis) or heart and blood vessel disorders. There’s no one-time fix for low testosterone in men.|Testosterone levels may drop as quickly as 30 minutes after you drink alcohol. To maintain healthy levels of vitamin D, try to get regular exposure to sunlight or consider taking a vitamin D3 supplement as directed by a healthcare professional. For both optimal health and hormone levels, try to manage your stress levels.|The AUA and the Testosterone Panel were committed to creating a Guideline that ensures that men in need of testosterone therapy are treated effectively and safely. Guidance is also given on the management of patients with cardiovascular disease, men who are interested in preserving their fertility and men who are at risk for or have prostate cancer. The Evaluation and Management of Testosterone Deficiency AUA Guideline provides guidance to the practicing clinician on how [best place to buy testosterone](https://tripleoggames.com/employer/sleep-testosterone-does-sleep-affect-testosterone-levels/) diagnose, treat and monitor the adult male with [buy testosterone without prescription](http://www.xngel.com/@melody19t0001?page=about) deficiency. Everlywell offers at-home hormone tests, including testosterone testing, so you can track your levels conveniently and confidentially. Testosterone plays a key role in sexual development, reproductive function, body composition, energy levels, and mood. "Everyone agrees that if you have a phenomenally low level, you’d benefit from treatment. Afternoon tests may give a false impression of low levels."|Given the growing concern and need for proper [buy testosterone without prescription](https://unitedpool.org/employer/effect-of-different-garlic-preparations-on-testosterone-thyroid-hormones-and-some-serum-trace-elements-in-rats/) therapy, the AUA identified a need to produce an evidence-based document that informs clinicians on the proper evaluation and management of [testosterone buy online](http://demo.sunflowermachinery.com/leannadenson62) deficient patients. Testosterone therapy should not be commenced for a period of three to six months in patients with a history of a cardiovascular events. Patients should be informed that there is no definitive evidence linking testosterone therapy to a higher incidence of venothrombolic events. Clinicians should inform patients of the absence of evidence linking testosterone therapy to the development of prostate cancer. Patients should be informed that the evidence is inconclusive whether [buy testosterone cream](https://allyoutubes.com/@izettasaraneal?page=about) therapy improves cognitive function, measures of diabetes, energy, fatigue, lipid profiles, and quality of life measures. Patients should be informed that testosterone therapy may result in improvements in erectile function, low sex drive, anemia, bone mineral density, lean body mass, and/or depressive symptoms.|Treatment plans usually include goals such as symptom relief, stabilization of testosterone levels within a target range, and minimizing risks. A clear, documented plan for monitoring testosterone levels, testosterone-related risks, and periodic re-evaluation is often required to maintain readiness while on TRT. Given the known risks of testosterone therapy and the lack of evidence for  [befamous.cyou](https://befamous.cyou/@fernhoch27661?page=about) clinical benefits in normal men, we do not think further trials of testosterone are necessary. A large cohort study found that myocardial infarction rates were significantly increased within three months of testosterone treatment initiation; testosterone-treated men over 65 experienced double the rate of myocardial infarctions compared to men who did not received testosterone. Studies that examined clinical effects have not favored testosterone therapy over placebo.|Two of the trials and one meta-analysis pointed to an increased risk of cardiovascular events,363, 364, 366 two revealed no cardiovascular risk,233, 367 and one was neutral with respect to risk.373 The Corona meta-analysis,372 which showed that there was no increased risk of cardiovascular events, was not officially reviewed but was taken into consideration in the final analysis. These findings are supported by a multi-institutional study that reported that with variable dosing and clinical protocols, most men required re-implantation after four months, with all men returning to sub therapeutic levels by six months.447 Men with total testosterone level 315 ng/dL declined from 100% at 4 weeks to 86%, 75%, and 14% by 12, 20, and 24 weeks, respectively. Further individualization may be considered based on trough testosterone levels at the end of a 10-week injection cycle. One study reported comparative pharmacokinetics between IM testosterone enanthate (250 mg every 3 weeks) and IM testosterone undenaconate (1,000 mg every 9 weeks, a dosage that is only available outside the United States).440 Results demonstrated that IM testosterone enanthate achieved trough levels of 239 ng/dL compared to 470 ng/dL with IM testosterone undecanoate at the end of the 10-week cycle.|Likewise, while some literature suggests that food ingestion might affect testosterone levels, the evidence is particularly weak, and the Panel does not recommend that clinicians insist on fasting prior to testing. Among men with traditional (10p.m. to 6a.m.) sleep patterns, peak testosterone values occur around 3-8a.m., with 32-39% of the diurnal total decline occurring within the first 30 minutes of waking.18-23 Older men experience diurnal blunting and more stability in testosterone levels throughout the day, while younger men undergo greater variation. Likewise, while some literature suggests that food ingestion might affect testosterone levels, the evidence is particularly weak, and the Panel does not recommend that clinicians insist on fasting prior to testing.Circadian Rhythm.}
+He has consulted for manufacturers of testosterone products, but never about testosterone. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Our Find a Provider tool makes it easy to search Cleveland Clinic’s trusted network. Cleveland Clinic’s experts can help balance your hormones. See a provider and discuss your options for treatment. If you have bothersome signs of low testosterone, avoid over-the-counter supplements.
+Although 1 injection study found an improvement on the Alzheimer Disease Assessment Scale-Cognitive Subscale (ADAS-COG), another study using testosterone gel found no effect on the same instrument or on other cognitive function tests. Spatial cognition/memory was reported to be improved with testosterone supplementation in 3 studies,114, 131, 132 unchanged in 2 studies,42, 133 and poorer with supplementation in 1 study. Twenty-two studies evaluating the effects of testosterone on cognition are summarized in Table 5. A subsequent, larger study by the same group showed no difference in response of depression measured by HAM-D or BDI in men given testosterone compared to placebo. Because it has been noted that HIV-positive men can be depressed and "hypogonadal," 3 studies administered testosterone to HIV-positive men with depression or dysthymia.35, 129, 130 Two of the studies had a Jadad score of 435, 130 and one study had a Jadad score of 3. Two studies in men with cognitive impairment or Alzheimer disease (Jadad score 3) found no effect of treatment on neuropsychiatric symptoms, depression, behavior, or quality of life (QoL).42, 124 Caregiver-assessed QoL was improved in 1 of these studies. The authors used an intention-to-treat (ITT) analysis and implied that better results were seen among subjects who completed the study; however, there were no significant differences in the depression scores between testosterone and placebo among completers.
+Only 1% of male breast enlargement is caused by malignancy,76 however with any enlargement of the male breast, the possibility of carcinoma should be considered. Histologically, the male breast contains both glandular and fatty tissue, and although gynecomastia may result from proliferation in either or both, proliferation of only the fatty tissue is termed pseudogynecomastia. The scientific literature examining the relationship between ED and low testosterone is further limited by the variability in, or absence of, the definition of ED, incomplete vascular comorbidity information, as well as variability in the thresholds used to define low testosterone. Studies whose primary endpoint was to measure the association between depression and low testosterone found that men with low testosterone have a significantly higher incidence of depression as well as a shorter time to onset of depression. At this time, there is no definitive evidence indicating what the optimal time interval should be between the two separate tests.
+Forty-five studies evaluating the effect of testosterone on mood and behavior are summarized in Table 4. Few studies investigated the use of testosterone supplementation in men younger than 60 years. Seven of 12 studies on erectile dysfunction with a Jadad score of 4 or 5 found a benefit.
+<br>
\ No newline at end of file